Showing results (11-20 of 71) with videos related to
Sort By:
Pageof 8
Urology|February 5, 1999
Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancerN J Vogelzang, W M StadlerJournal of Cardiovascular Pharmacology|February 1, 1993
Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP-dependent potassium channelL Chi, S C Black, P I Kuo, et al.West African Journal of Medicine|April 1, 1994
Computerized tomographic findings in adolescent and adult Nigerian epilepticsA Ogunniyi, A Adeyinka, S O Fagbemi, et al.International Journal of Oncology|August 12, 2000
A G2/M growth arrest response to low-dose intermittent H2O2 in normal uroepithelial cellsM Chien, C Rinker-Schaeffer, W M StadlerUrology|December 18, 2001
Nilutamide: possible utility as a second-line hormonal agentA Desai, W M Stadler, N J VogelzangThe Journal of Urology|March 21, 1998
Expression of bcl-2 and bcl-X in bladder cancerE J Kirsh, D A Baunoch, W M StadlerSeminars in Oncology|October 31, 2001
Docetaxel and exisulind in hormone-refractory prostate cancerC W Ryan, W M Stadler, N J VogelzangCancer|November 1, 1995
A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinomaW M Stadler, M E Rybak, N J VogelzangUrology|February 1, 1996
High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: the University of Chicago experienceK L Shulman, W M Stadler, N J VogelzangPageof 8